EE360 Health Care Resource Utilization With Asciminib and Bosutinib Among Adults With Chronic Myeloid Leukemia in Chronic Phase Previously Treated With ≥2 Tyrosine Kinase Inhibitors: Week 48 and Week 96 Results From ASCEMBL Trial
Abstract
Authors
JE Cortes K Sasaki D Réa MJ Mauro D Tran P Wang K Jadhav L Di Caprio A Yocolly